
Anbarasan Sekar
@anbarasan_onc
Assistant professor medical oncology ACTREC Tata memorial centre. Father. Traveller
servicing humanity
ID: 1546363349985660928
11-07-2022 05:19:00
78 Tweet
233 Takipçi
514 Takip Edilen




Tata Memorial Hospital Gaurav Narula MD Hasmukh Jain proud contribution to pathbreaking indigenous CAR-T treatment for lymphoma/leukemia in collaboration with Rahul Purwar IIT Bombay !Gratitude to Hon’ble President of India ! DAE India Tata Memorial Centre, Varanasi (MPMMCC & HBCH) HBCHRC,VIZAG - TATA MEMORIAL CENTRE Tata Memorial Centre, HBCH & RC,Punjab TMC Radiation Oncology

In our new endeavour, women from diverse corners of the country unite with Sanjeev Kapoor who cooks up some food for thought & champions breast cancer awareness through promotion of regular self-breast examination for early detection.

Phase III randomized trial of neoadjuvant paclitaxel+platinum to 5-fluorouracil+platinum in esophageal/GEJ squamous cell carcinoma academic.oup.com/jnci/article-a…. Paclitaxel Platinum is as good as platinum 5 FU. Vanita Noronha, MBBS MD DM Nandini Menon bhawna sirohi Dr Amol Akhade Amol Patel



Thanks Vertika Was a labour of love with Prathamesh Pai and Terry Jones. Pleased to hold it in my hands today. Thanks to global expert authorship for their generous contributions (too numerous to mention); Robert Ferris, MD, PhD John Watkinson Ralph Gilbert for beautiful foreword




youtu.be/fNJg8fSrvmo?si… A journey of courage, told by the one who lived it. 💖 Watch Dr. Vanita Noronha, MBBS MD DM turn her battle with breast cancer into a source of strength and hope. 🔗 Premieres at 9 45 AM IST on 27.2.25 Tata Memorial Hospital ACTREC-TMC Devieka Bhojwani

📢CAR T-cells for relapsed/refractory B-cell malignancies in India: phase 1/2 trial 📈Safety: no ICANS, low incidence of severe CRS, manageable haematological toxicities, 2 treatment-related deaths. 🔍Activity: 73% overall response rate.Rahul Purwar 👇 shorturl.at/x11Ip

After consecutive extended resections for cholangiocarcinomas... A series of Parenchyma sparing Hepatectomies (PSH) for CRLMs. Key to sucess... Appropriate use of preoperative chemo Meticulous pre-op planning Real-time intra-op navigation with IOUS & ICG Mahesh Goel Shraddha Patkar

Indian real-world data (JCO Global Oncology) confirms trastuzumab before/after surgery + maintenance enhances survival in HER2-positive breast cancer, esp when pCR achieved. Need early dx & universal access to HER2 drugs in LMICs. doi.org/10.1200/GO-24-… #GlobalOnc


ACTREC-TMC JCO Global Oncology Tata Memorial Hospital Anbarasan Sekar Prabhat Bhargava, DM (Medical Oncology) Seema Gulia Rajiv Sarin MD Jyoti Bajpai Dr Shalaka Joshi TMC Breast DMG Excellent data, with > 70 months of follow up. Access to HER2 targeted therapy, and longer duration of use (> 6 months) improves survival in patients with locally advanced HER2+ breast cancer. Congratulations to Sudeep sir, and the entire team of breast oncology at TMC, Mumbai.

The Nobel Prize laureate Sir Paul Nurse gave an enlightening talk on Controlling the Cell Cycle at Tata Memorial Hospital, attended by a distinguished audience of doctors & scientists DAE India Bhabha Atomic Research Centre. It is available on our YT channel (link ahead). The thought provoking lecture was..
